Trial intelligence / Profile preview

Chamomile versus calendula creams for prevention of radiation-induced skin lesions

RBR-98myd6Recruiting

Sponsor
Daniele Machado Oliveira Andrade
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Single-blind trial of chamomile and calendula in radiodermatitis and head and neck cancer (HNC) (2 arms), sponsored by Daniele Machado Oliveira Andrade. Primary endpoint: Prevention of radiation-induced skin lesions. Started Feb 2020; status: recruiting.

02

Drugs

chamomilecalendula
03

Conditions

radiodermatitishead and neck cancer (HNC)

Beyond the preview

Go deeper on RBR-98myd6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-98myd6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call